Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now displays a 403 error with a Home button, replacing the previous study details and related information.SummaryDifference16%

- Check19 days agoChange DetectedThe page now displays a 403 Forbidden error page with standard header/footer, replacing the previous detailed study record content and metadata.SummaryDifference16%

- Check40 days agoChange DetectedThe page now shows No longer looking for participants and lists 226 study locations (down from 264). It also updates the primary completion date to 2026-08-10 and the study completion date to 2027-09-08, with a protocol revision noted as Revision: v3.6.6.SummaryDifference6%

- Check62 days agoChange DetectedThe page footer now displays Revision: v3.6.5, up from Revision: v3.6.4, indicating a deployment update.SummaryDifference0.0%

- Check76 days agoChange DetectedThis change updates the revision from v3.6.3 to v3.6.4, indicating a small update to the page's documentation or release notes. It does not alter the page's primary information or user-facing features.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page text remains unchanged. No new content or deletions were detected in the study record.SummaryDifference0.0%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.